CTB news banner

Breadcrumb

Asset Publisher

Novel gene therapy trial offers hope to patients with rare metabolic disease

Samuel is the first Canadian and the ninth patient worldwide to participate in the second phase of a study using gene therapy to treat Glycogen storage disease type I, otherwise known as GSD.

Canadian researchers work together to develop made-in-Canada COVID-19 testing capacity

The road towards Canadian testing capacity began in Montreal

COVID-19 impact on cancer patients: MUHC researchers take part in a multinational study

Published in The Lancet, the study reveals cancer-specific factors associated with increased mortality

Made-in-Canada COVID-19 test developed at McGill receives government support

Government support for McGill and RI-MUHC team in COVID-19 testing

Largest synthesis of known protein-protein interactions published in the journal Nature

RI-MUHC researchers on international team that produced the blueprint

RI-MUHC researchers review diagnostic tests for COVID-19

Study published in the Annals of Internal Medicine

International consortium investigates overactive immune cells as cause of COVID-19 deaths

New publication links neutrophil infiltration in the lungs of patients to COVID-19 symptoms

February winner of the Relève étoile Jacques-Genest award

Congratulations to Anne-Julie Tessier, doctoral student at the RI-MUHC!

Pediatric researchers in Montreal unite to tackle infection and immunity on two different fronts

Two inter-institutional teams start research projects to address rare immune diseases and antibiotic overuse

Overcoming the greatest obstacle to curing HIV

RI-MUHC researcher participated in the groundbreaking study published in Nature

High-fat diet proven to fuel prostate cancer progression by imitating a key cancer alteration

What molecular event happens for prostate cancer to progress faster and to be deadlier when patients eat a high-fat diet?

Cellular origins of pediatric brain tumours identified

Research team from the Lady Davis Institute, RI-MUHC and SickKids uses new technologies to “interrogate” tumour cells

Rare respiratory diseases: Combining immunology and respiratory expertise for children and adults

The RI-MUHC is one of eight research centres participating in an NIH-funded project to accelerate the understanding of rare suppurative respiratory diseases and innovate in the field

Dr. I. George Fantus receives Lifetime Achievement Award from Diabetes Canada

Acclaim for a career combining love of science with caring for people

The MUHC teams up with LSU Health New Orleans to advance Usher Syndrome antisense therapy research

Researchers collaborate to treat vision loss linked to Usher thanks to a 1.74 million USD grant from the National Institutes of Health

Celebrating the twentieth anniversary of the GPCR Retreat

Fast-forward to more years of innovative research on G protein-coupled receptors (GPCR) ahead of us!

Pediatric neurologist dedicates her career to leukodystrophies

Geneviève Bernard, MD, FRCPC, is this year’s recipient of the Prix d’excellence – Specialist of the Year award for Region 4

So much to discover: Research in the era of legal cannabis

Interview with Carolyn Baglole, director of the new McGill Research Centre for Cannabis

Sepsis: testing before starting treatment is essential

Timely administration of appropriate antibiotics is essential to prevent death in patients with severe infections. Can healthcare teams “skip” drawing blood for bacterial cultures?

A close look at the progression of cells from normal to tumour

How exactly does a normal cell become a tumour?

See Archive - CTB News